Prio Wealth Limited Partnership’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$60.8M Sell
725,424
-29,019
-4% -$2.43M 1.78% 13
2024
Q2
$58.1M Sell
754,443
-95,373
-11% -$7.34M 1.73% 13
2024
Q1
$58.2M Buy
849,816
+55,167
+7% +$3.78M 1.68% 16
2023
Q4
$45.9M Sell
794,649
-19,116
-2% -$1.11M 1.58% 18
2023
Q3
$43M Sell
813,765
-61,480
-7% -$3.25M 1.65% 17
2023
Q2
$47.3M Sell
875,245
-220,076
-20% -$11.9M 1.69% 16
2023
Q1
$54.8M Sell
1,095,321
-22,733
-2% -$1.14M 2.1% 9
2022
Q4
$51.7M Sell
1,118,054
-36,691
-3% -$1.7M 2.07% 11
2022
Q3
$44.7M Buy
1,154,745
+11,077
+1% +$429K 1.92% 13
2022
Q2
$42.6M Sell
1,143,668
-29,491
-3% -$1.1M 1.7% 15
2022
Q1
$52M Buy
1,173,159
+13,123
+1% +$581K 1.72% 16
2021
Q4
$49.3M Buy
1,160,036
+7,815
+0.7% +$332K 1.51% 19
2021
Q3
$50M Buy
1,152,221
+16,334
+1% +$709K 1.68% 18
2021
Q2
$48.6M Sell
1,135,887
-234
-0% -$10K 1.64% 18
2021
Q1
$43.9M Buy
1,136,121
+53,731
+5% +$2.08M 1.58% 20
2020
Q4
$38.9M Buy
1,082,390
+12,343
+1% +$444K 1.46% 23
2020
Q3
$40.9M Buy
1,070,047
+19,521
+2% +$746K 1.7% 17
2020
Q2
$36.9M Buy
1,050,526
+23,987
+2% +$842K 1.7% 16
2020
Q1
$33.5M Sell
1,026,539
-4,554
-0.4% -$149K 1.85% 15
2019
Q4
$46.6M Buy
1,031,093
+11,287
+1% +$510K 1.98% 14
2019
Q3
$41.5M Sell
1,019,806
-7,349
-0.7% -$299K 1.9% 15
2019
Q2
$44.1M Sell
1,027,155
-1,880
-0.2% -$80.8K 2.03% 14
2019
Q1
$39.5M Sell
1,029,035
-14,611
-1% -$561K 1.85% 17
2018
Q4
$36.9M Sell
1,043,646
-3,393
-0.3% -$120K 1.97% 16
2018
Q3
$40.3M Buy
1,047,039
+33,407
+3% +$1.29M 1.84% 17
2018
Q2
$33.1M Sell
1,013,632
-18,674
-2% -$611K 1.64% 19
2018
Q1
$28.2M Sell
1,032,306
-26,090
-2% -$713K 1.41% 26
2017
Q4
$26.2M Buy
1,058,396
+6,415
+0.6% +$159K 1.22% 27
2017
Q3
$30.7M Sell
1,051,981
-5,564
-0.5% -$162K 1.5% 21
2017
Q2
$29.3M Buy
1,057,545
+847,615
+404% +$23.5M 1.46% 22
2017
Q1
$5.22M Buy
+209,930
New +$5.22M 0.27% 78